CXCL16 and breast carcinoma: Indeed, as shown for stromal PDE5 levels, increased stromal expression of CXCL16 was found in breast cancer stroma compared to the corresponding normal tissue stroma and was associated with poor overall survival in Kaplan–Meier analysis.